{
    "organizations": [],
    "uuid": "ddeb4d3bbfed42b0247a6faeb2fa53030734f868",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acceleron-reports-q1-loss-per-shar/brief-acceleron-reports-q1-loss-per-share-0-58-idUSASC0A0KX",
    "ord_in_thread": 0,
    "title": "BRIEF-Acceleron Reports Q1 Loss Per Share $0.58",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Acceleron Pharma Inc:\n* ACCELERON REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS\n* ACCELERON PHARMA - BELIEVES EXISTING CASH, CASH EQUIVALENTS & INVESTMENTS TO BE SUFFICIENT TO FUND PROJECTED OPERATING REQUIREMENTS INTO 2021\n* ACCELERON PHARMA INC - QTRLY LOSS PER SHARE $0.58\n* ACCELERON PHARMA INC - QTRLY COLLABORATION REVENUE $3.2 MILLION VERSUS $3.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T04:50:00.000+03:00",
    "crawled": "2018-05-09T12:20:48.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "acceleron",
        "pharma",
        "inc",
        "acceleron",
        "report",
        "first",
        "quarter",
        "operating",
        "financial",
        "result",
        "acceleron",
        "pharma",
        "belief",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "sufficient",
        "fund",
        "projected",
        "operating",
        "requirement",
        "acceleron",
        "pharma",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "acceleron",
        "pharma",
        "inc",
        "qtrly",
        "collaboration",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}